东江集团控股(02283.HK):Smart device stodrive earnings growth
2018-03-20 15:47:53
来源:
格隆汇
机构:信达证券
评级:买入
目标价:7.53港元
In-line FY 17 result but GM surprise on the upside
Though TK’s FY17 result was generally in-line with both market consensusand our estimates (with revenue grew 14.4% to HK$1,860mn, while net profitattributable to shareholders soared 46.7% to HK$302mn, driven by GMexpansion in both business segments. GM expanded 560bps to 33.7% (arecord high throughout the track record period), which was 80bps/120bpsabove market and our estimates. The GM beat was driven by i) betteroperating efficiency through automation (700bps impact), and Euroappreciation (200 bps impact on GM) which led to mold fabrication GM soared900bps to 37.4% and ii) Utilization rate improvement in plastic injectionsegment (up 960bps Yoy). We continue to see TK’s GM still possesses anupside due to: i) TK’s automobile segment order backlog to driveultra-large molds revenue (GM at 30%-40%), ii) Utilization andautomation enhancement in both mold fabrication and plastic injectionsegments; iii) strong order backlogs from mobile phones & wearables,medical & health devices, and smart home device (togther withautomobile backlog, accounted for 67% of total at ~HK$800mn). In viewof strong order backlogs, we see TK’s revenue guidance of ~20% growth inFY18E could be achieved.
Smart home segment picked up in 2H17, growth momentumcontinues in FY18E
Smart home revenue soared 132% Yoy to HK$210mn (11.3% of total revenuevs. 5.6% in 1H17), as consolidation between Google Home and Nest hasbeen completed, segment revenue came in at ~HK$166mn (vs. RMB 44.8mnin 1H17), up 304% Yoy and accounted for 79% of total segment revenue).Together We believe smart home segment growth in FY18E would be wellabove group level.
Consumer electronics, healthcare and medical devices continue todrive plastic injection GM; Seeking M&A opportunities for future growth
We expect utilization rate would continue to further improve in FY18E drivenby smartphone & wearables (US renowned clients’ launch of new flagships in2H18E, and new accessories/projects as being rumoured in market recently,e.g. New earphones and wireless charging products), healthcare & medicaldevices, together with stable procurement cost (in RMB), we expect theplastic injection segment GM to stay >30% in FY18E. TK’s guidance onFY18E CAPEX would be ~HK$230mn, which will be mainly used in capacityexpansion and production automation. In view of customers’ order demand,TK is seeking various ways to further expand their capacity, e.g. to build new/rent production sites, and also to look at M&A opportunities.
Maintain BUY on FY18E 13.1x PE, fundamentals remains solid
We raised TK’s FY18E EPS by 14.8% and introduced FY19E EPS. TK istrading at FY18E 13.1x PE ( ~15% discount to Hong Kong and internationalpeers), with TK’s EPS growth at 22.6% CAGR in FY17-19E) driven by existingclients’ product pipeline, ramp up of new clients’ order as well as GMexpansion. We raised TK’s TP from HK$4.34 to HK7.53 which translates toFY18E 15.8x PE (vs. 10.4x PE in our last update in Aug 2017, and par topeers on its decent track record, and healthy financial position to financeCAPEX), we expect TK would be able to maintain dividend payout ratio>40%, its 3.6%/4.2% dividend yield in FY18E/19E continue to make it a gooddefensive play, we reiterate TK’s rating at BUY.
全部评论
机会情报
- 固态电池催化连连!电池企业盯上低空市场,完美契合eVTOL市场需求
- 六部门部署开展绿色建材下乡活动,关注行业龙头估值修复契机
- 首次实现无人机跨海货运,低空经济蓝图加速落地
- 北京推进算力基础设施建设,2027年将实现全栈自主可控
- 海运市场掀起“涨价潮”,上海港、宁波港部分船司出现大柜供应紧俏问题
- 国务院发话!推动头部证券公司做强做优,中信证券、国联证券、东方财富等三类券商望受益
- 碳价突破百元大关,碳资产投资风口有望卷土重来
- 四川省职业教育条例5月1日起施行,差异化能力民办中职有望脱颖而出
- HBM霸主SK海力士产能版图再扩张,HBM市场有望快速增长
- 无人机项目首次入选智能交通试点,券商预计万亿市场开启